AGNP-Exam 2 Questions With Correct
Answers
aldosterone
Hormone that stimulates the kidney to retain sodium ions and water
| | | | | | | | | |
HAP
nosocomial
VAP
48-72 hours after intubation
| | |
CAP
community acquired pneumonia
| |
acute inflammation of pulmonary parenchyma acquired in community
| | | | | | |
,CAP antibiotics
|
Macrlides (Zpack) |
Cephalsporins (rocephin/cefepime, zosyn for broad) | | | |
Fluroquinolones (levaquin/moxifloxacin)-po and iV | | |
HCAP
acquired in HCFacility | |
IV therapy, wound care or iv chemo within 30 days
| | | | | | | | |
NH or LTF
| |
hospitalization 2-3 days within last 90 | | | | |
hospital or dialysis in last 30
| | | | |
HCAP Antibiotics
|
add vanco for MRSA
| | |
add flagyl for possible aspiration
| | | |
G+C for PNA
| |
Strep pneumoniae (COPD)
| |
,Strep pyogenes (Group A)
| | |
Strep agalactiae (group B)
| | |
S. Aureus
|
G+R for PNA
| |
bacillus anthracis |
nocardia sp. (chronic PNA ) | | | |
G-C for PNA
| |
Nieressa Menigits |
G-R for PNA
| |
klebsilla pneumoniae |
e.coli
pseudomona aeroginosa (COPD and CF) | | | |
Anaerobes for PNA | |
, Acintebactor Sp. |
Burkholderia pseudomallei |
hemophillis influenza (COPD) | |
Bordetella pertusus -Whooping
| |
proteus sp. |
serratia sp. |
Atypical Pathogens for PNA
| | |
M Tuberculosis (chronic PNA)
| | |
legionella pneumophilia
|
mycloplasma pneumonia |
chlamydia tracematis |
chlamydia pneumonia |
Risk factors for PNA- 1
| | | |
travel, animal, occupation, envirnmental (ie air condition)
| | | | | |
Aspirations risk for PNA | | |
Answers
aldosterone
Hormone that stimulates the kidney to retain sodium ions and water
| | | | | | | | | |
HAP
nosocomial
VAP
48-72 hours after intubation
| | |
CAP
community acquired pneumonia
| |
acute inflammation of pulmonary parenchyma acquired in community
| | | | | | |
,CAP antibiotics
|
Macrlides (Zpack) |
Cephalsporins (rocephin/cefepime, zosyn for broad) | | | |
Fluroquinolones (levaquin/moxifloxacin)-po and iV | | |
HCAP
acquired in HCFacility | |
IV therapy, wound care or iv chemo within 30 days
| | | | | | | | |
NH or LTF
| |
hospitalization 2-3 days within last 90 | | | | |
hospital or dialysis in last 30
| | | | |
HCAP Antibiotics
|
add vanco for MRSA
| | |
add flagyl for possible aspiration
| | | |
G+C for PNA
| |
Strep pneumoniae (COPD)
| |
,Strep pyogenes (Group A)
| | |
Strep agalactiae (group B)
| | |
S. Aureus
|
G+R for PNA
| |
bacillus anthracis |
nocardia sp. (chronic PNA ) | | | |
G-C for PNA
| |
Nieressa Menigits |
G-R for PNA
| |
klebsilla pneumoniae |
e.coli
pseudomona aeroginosa (COPD and CF) | | | |
Anaerobes for PNA | |
, Acintebactor Sp. |
Burkholderia pseudomallei |
hemophillis influenza (COPD) | |
Bordetella pertusus -Whooping
| |
proteus sp. |
serratia sp. |
Atypical Pathogens for PNA
| | |
M Tuberculosis (chronic PNA)
| | |
legionella pneumophilia
|
mycloplasma pneumonia |
chlamydia tracematis |
chlamydia pneumonia |
Risk factors for PNA- 1
| | | |
travel, animal, occupation, envirnmental (ie air condition)
| | | | | |
Aspirations risk for PNA | | |
